{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:43:17Z","timestamp":1771461797024,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T00:00:00Z","timestamp":1448668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00392-015-0945-x","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T17:19:23Z","timestamp":1448731163000},"page":"489-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect"],"prefix":"10.1007","volume":"105","author":[{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[]},{"given":"Pedro Bettencourt","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Henrique Cyrne","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"David","family":"K\u00e9nizou","sequence":"additional","affiliation":[]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,11,28]]},"reference":[{"key":"945_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K\u00f8ber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R\u00f8nnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869","journal-title":"Eur J Heart Fail"},{"issue":"3\u20134","key":"945_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96(3\u20134):132\u2013143","journal-title":"Cardiology"},{"issue":"2","key":"945_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00424-008-0616-0","volume":"458","author":"M Gekle","year":"2009","unstructured":"Gekle M, Grossmann C (2009) Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch 458(2):231\u2013246","journal-title":"Pflugers Arch"},{"key":"945_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCHEARTFAILURE.108.770834","volume":"1","author":"RW Schrier","year":"2008","unstructured":"Schrier RW (2008) Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1:2\u20135","journal-title":"Circ Heart Fail"},{"key":"945_CR5","first-page":"450","volume":"102","author":"CS Wilcox","year":"1983","unstructured":"Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF (1983) Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102:450\u2013458","journal-title":"J Lab Clin Med"},{"key":"945_CR6","doi-asserted-by":"crossref","unstructured":"Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, Braunwald E, O\u2019Connor CM, Felker GM (2012) Markers of decongestion, dyspnea relief and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246"},{"issue":"1","key":"945_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11897-006-0030-x","volume":"3","author":"S Iyengar","year":"2006","unstructured":"Iyengar S, Abraham WT (2006) Diuretic resistance in heart failure. Curr Heart Fail Rep 3(1):41\u201345","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"945_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","volume":"16","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JG, Anker SD, Gheorghiade M, Fiuzat M, Rossignol P, Zannad F, Pitt B, O\u2019Connor C, Felker GM (2014) Decongestion in acute heart failure. Eur J Heart Fail 16(5):471\u2013482","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"945_CR9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cardfail.2014.03.006","volume":"20","author":"D Singh","year":"2014","unstructured":"Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W, Tang WH (2014) Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 20(6):392\u2013399","journal-title":"J Card Fail"},{"issue":"617","key":"945_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/pgmj.53.617.117","volume":"53","author":"WD Alexander","year":"1977","unstructured":"Alexander WD, Branch RA, Levine DF, Hartog M (1977) The urinary sodium: potassium ratio and response to diuretics in resistant oedema. Postgrad Med J 53(617):117\u2013121","journal-title":"Postgrad Med J"},{"key":"945_CR11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1479-5876-9-180","volume":"9","author":"RJ Eudy","year":"2011","unstructured":"Eudy RJ, Sahasrabudhe V, Sweeney K, Tugnait M, King-Ahmad A, Near K, Loria P, Banker ME, Piotrowski DW, Boustany-Kari CM (2011) The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. J Transl Med 9:180","journal-title":"J Transl Med"},{"issue":"10","key":"945_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00392-013-0588-8","volume":"102","author":"JP Ferreira","year":"2013","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2013) Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors. Clin Res Cardiol 102(10):745\u2013753","journal-title":"Clin Res Cardiol"},{"issue":"7123","key":"945_CR13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(60)90448-7","volume":"1","author":"CJ Edmonds","year":"1960","unstructured":"Edmonds CJ (1960) An aldosterone antagonist and diuretics in the treatment of chronic oedema and ascites. Lancet 1(7123):509\u2013515","journal-title":"Lancet"},{"issue":"19","key":"945_CR14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2011.04.049","volume":"58","author":"P Rossignol","year":"2011","unstructured":"Rossignol P, Menard J, Fay R, Gustafsson F, Pitt B, Zannad F (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58(19):1958\u20131966","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"945_CR15","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/eurheartj\/ehr170","volume":"32","author":"M Albaghdadi","year":"2011","unstructured":"Albaghdadi M, Gheorghiade M, Pitt B (2011) Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur Heart J 32(21):2626\u20132633","journal-title":"Eur Heart J"},{"issue":"4","key":"945_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","volume":"2","author":"S Bansal","year":"2009","unstructured":"Bansal S, Lindenfeld J, Schrier RW (2009) Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail. 2(4):370\u2013376","journal-title":"Circ Heart Fail."},{"issue":"1","key":"945_CR17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2013","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H (2013) Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med. 25(1):67\u201372","journal-title":"Eur J Intern Med."},{"key":"945_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 130:461\u2013470","journal-title":"Ann Intern Med."},{"issue":"10","key":"945_CR19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurjhf\/hft095","volume":"15","author":"F Zannad","year":"2013","unstructured":"Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Pi\u00f1a IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ (2013) Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 15(10):1082\u20131094","journal-title":"Eur J Heart Fail"},{"key":"945_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrneph.2011.14","volume":"7","author":"Z Ricci","year":"2011","unstructured":"Ricci Z, Cruz DN, Ronco C (2011) Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol 7:201\u2013208","journal-title":"Nat Rev Nephrol"},{"key":"945_CR21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"945_CR22","doi-asserted-by":"crossref","unstructured":"Pencina MJ, D\u2019Agostino RB, Sr., D\u2019Agostino RB, Jr., Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2): 157\u2013172, 207\u2013112","DOI":"10.1002\/sim.3106"},{"issue":"14","key":"945_CR23","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/sim.5647","volume":"32","author":"H Uno","year":"2013","unstructured":"Uno H, Tian L, Cai T, Kohane IS, Wei LJ (2013) A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med 32(14):2430\u20132442","journal-title":"Stat Med"},{"key":"945_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387","journal-title":"Stat Med"},{"issue":"4","key":"945_CR25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","volume":"34","author":"L Kang","year":"2015","unstructured":"Kang L, Chen W, Petrick NA, Gallas BD (2015) Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med 34(4):685\u2013703","journal-title":"Stat Med"},{"key":"945_CR26","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","volume":"111","author":"DL Mann","year":"2005","unstructured":"Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837\u20132849","journal-title":"Circulation"},{"issue":"3","key":"945_CR27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-101-3-370","volume":"101","author":"GS Francis","year":"1984","unstructured":"Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN (1984) The neurohumoral axis in congestive heart failure. Ann Intern Med 101(3):370\u2013377","journal-title":"Ann Intern Med"},{"key":"945_CR28","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mhj.2002.129969","volume":"144","author":"AD Struthers","year":"2002","unstructured":"Struthers AD (2002) Aldosterone: cardiovascular assault. Am Heart J 144:S2\u2013S7","journal-title":"Am Heart J"},{"issue":"22","key":"945_CR29","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/eurheartj\/ehs257","volume":"33","author":"F Zannad","year":"2012","unstructured":"Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, Struthers AD, Voors AA, Ruilope LM, Bakris GL, O\u2019Connor CM, Gheorghiade M, Mentz RJ, Cohen-Solal A, Maggioni AP, Beygui F, Filippatos GS, Massy ZA, Pathak A, Pi\u00f1a IL, Sabbah HN, Sica DA, Tavazzi L, Pitt B (2012) Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J 33(22):2782\u20132795","journal-title":"Eur Heart J"},{"issue":"10","key":"945_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, Randomized Aldactone Evaluation Study Investigators (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709\u2013717","journal-title":"N Engl J Med"},{"issue":"1","key":"945_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11\u201321","journal-title":"N Engl J Med"},{"key":"945_CR32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"issue":"15","key":"945_CR33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O\u2019Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392","journal-title":"N Engl J Med"},{"issue":"1","key":"945_CR34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","volume":"131","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O\u2019Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B (2015) Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial. Circulation 131(1):34\u201342","journal-title":"Circulation"},{"key":"945_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.114.013637","volume":"131","author":"P Rossignol","year":"2015","unstructured":"Rossignol P, Zannad F (2015) Regional differences in heart failure with preserved ejection fraction trials: when nephrology meets cardiology but East does not meet west. Circulation 131:7\u201310","journal-title":"Circulation"},{"key":"945_CR36","doi-asserted-by":"crossref","unstructured":"Ferreira JP, Girerd N, Rossignol P, Zannad F (2015) Geographic differences in heart failure trials. Eur J Heart Fail","DOI":"10.1002\/ejhf.326"},{"issue":"3","key":"945_CR37","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.ijcard.2013.11.023","volume":"170","author":"M Eng","year":"2014","unstructured":"Eng M, Bansal S (2014) Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure. Int J Cardiol 170(3):e68\u2013e69","journal-title":"Int J Cardiol"},{"key":"945_CR38","doi-asserted-by":"crossref","unstructured":"Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Vincent J, Pitt B, Zannad F (2015) Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial. Eur Heart J","DOI":"10.1093\/eurheartj\/ehv273"},{"issue":"2","key":"945_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","volume":"39","author":"J Santos","year":"2003","unstructured":"Santos J, Planas R, Pardo A, Dur\u00e1ndez R, Cabr\u00e9 E, Morillas RM, Granada ML, Jim\u00e9nez JA, Quintero E, Gassull MA (2003) Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J Hepatol 39(2):187\u2013192","journal-title":"J Hepatol"},{"issue":"5 Pt 1","key":"945_CR40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","volume":"84","author":"RM P\u00e9rez-Ayuso","year":"1983","unstructured":"P\u00e9rez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rod\u00e9s J (1983) Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the rennin\u2013aldosterone system. Gastroenterology 84(5 Pt 1):961\u2013968","journal-title":"Gastroenterology"},{"issue":"6","key":"945_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000168356","volume":"11","author":"J Hensen","year":"1991","unstructured":"Hensen J, Abraham WT, Durr JA, Schrier RW (1991) Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention. Am J Nephrol 11(6):441\u2013446","journal-title":"Am J Nephrol"},{"issue":"3","key":"945_CR42","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","volume":"71","author":"AA Vliet van","year":"1993","unstructured":"van Vliet AA, Donker AJ, Nauta JJ, Verheugt FW (1993) Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol 71(3):21A\u201328A","journal-title":"Am J Cardiol"},{"issue":"5","key":"945_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/clpt.1986.219","volume":"40","author":"HW Overdiek","year":"1986","unstructured":"Overdiek HW, Merkus FW (1986) Influence of food on the bioavailability of spironolactone. Clin Pharmacol Ther 40(5):531\u2013536","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"945_CR44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10741-005-2345-1","volume":"10","author":"DA Sica","year":"2005","unstructured":"Sica DA (2005) Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 10(1):23\u201329","journal-title":"Heart Fail Rev"},{"issue":"8","key":"945_CR45","first-page":"417","volume":"21","author":"L Ceremuzynski","year":"1983","unstructured":"Ceremuzynski L, Budaj A, Michorowski B (1983) Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation. Int J Clin Pharmacol Ther Toxicol 21(8):417\u2013421","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"1","key":"945_CR46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","volume":"2","author":"GM Felker","year":"2009","unstructured":"Felker GM, O\u2019Connor CM, Braunwald E (2009) Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2(1):56\u201362","journal-title":"Circ Heart Fail"},{"issue":"2","key":"945_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209\u2013216","journal-title":"Am Heart J"},{"issue":"9","key":"945_CR48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O\u2019Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805","journal-title":"N Engl J Med"},{"issue":"12","key":"945_CR49","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","volume":"4","author":"M Sarraf","year":"2009","unstructured":"Sarraf M, Masoumi A, Schrier RW (2009) Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 4(12):2013\u20132026","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"945_CR50","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1517\/14656566.2013.808332","volume":"14","author":"P Rossignol","year":"2013","unstructured":"Rossignol P, Zannad F (2013) Loop diuretics and ultrafiltration in heart failure. Expert Opin Pharmacother 14(12):1641\u20131648","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"945_CR51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.V1271335","volume":"12","author":"JG Abdallah","year":"2001","unstructured":"Abdallah JG, Schrier RW, Edelstein C, Jennings SD, Wyse B, Ellison DH (2001) Loop diuretic infusion increases thiazide-sensitive Na(+)\/Cl(\u2212)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol 12(7):1335\u20131341","journal-title":"J Am Soc Nephrol"},{"issue":"1 Suppl","key":"945_CR52","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/01.CCM.0000296272.68078.6B","volume":"36","author":"DJ Wang","year":"2008","unstructured":"Wang DJ, Gottlieb SS (2008) Diuretics: still the mainstay of treatment. Crit Care Med 36(1 Suppl):S89\u2013S94","journal-title":"Crit Care Med"},{"issue":"5","key":"945_CR53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ahj.2011.02.005","volume":"161","author":"JM Testani","year":"2011","unstructured":"Testani JM, Cappola TP, McCauley BD, Chen J, Shen J, Shannon RP, Kimmel SE (2011) Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization. Am Heart J 161(5):944\u2013949","journal-title":"Am Heart J"},{"issue":"1","key":"945_CR54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2008.08.004","volume":"138","author":"P Velavan","year":"2010","unstructured":"Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M, Follath F, Swedberg K, Madeira H, Cleland JG (2010) Predictors of short term mortality in heart failure\u2014insights from the Euro Heart Failure survey. Int J Cardiol 138(1):63\u201369","journal-title":"Int J Cardiol"},{"issue":"20","key":"945_CR55","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","volume":"60","author":"O Vardeny","year":"2012","unstructured":"Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60(20):2082\u20132089","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"945_CR56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7(2):261\u2013270","journal-title":"Circ Heart Fail"},{"issue":"7","key":"945_CR57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MA, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455\u2013469","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-015-0945-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0945-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T16:15:02Z","timestamp":1653668102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-015-0945-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,28]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s00392-015-0945-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,28]]}}}